---
name: I3.1 Management of CIN2 in Those Who Are Concerned About the Potential Effect of Treatment on Future Pregnancy Outcomes 

externalData:
- resources

data:
- 
  resourceType: Patient
  name: Joanne Smith
  gender: female
  birthDate: 1991-01-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F
- 
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#285838002 Cervical intraepithelial neoplasia grade 2 (disorder)
  effectiveDateTime: 2021-05-01
- 
  resourceType: Observation
  code: http://OUR-PLACEHOLDER-URL.com#FPCQ Does the patient have future pregnancy concerns related to treatment options?
  status: final
  valueCodeableConcept: SNOMEDCT#373066001 Yes (qualifier value)
  effectiveDateTime: 2021-05-01

results:
  Recommendation:
    short: 'Surveillance or Treatment'
    date: '2021-06-02'
    group: 'Managing Histology (I.3)'
    details: 
      - "Either observation or treatment of CIN 2 is acceptable when the patient's concerns about the effect of treatment on future pregnancy outweigh concerns about cancer."
      - 'Observation is unacceptable when the squamocolumnar junction or the upper limit of the lesion is not fully visualized or when the results of an endocervical sampling, if performed, is CIN 2+ or ungraded.'
      - 'Observation includes colposcopy and primary hrHPV testing or cotesting at 6-month intervals for up to 2 years.'
    id: '5.I.3.1.a'